Abstract
Lung cancer (LC) in young patients (pts) is uncommon. Despite a reduction in smoking prevalence, the incidence of LC in young pts in the UK remains stable. Real world evidence on the clinicopathological characteristics, management and outcomes of young pts remains sparse.
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have